CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-30 | Rona Jeffrey A Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2020-08-28 | LEVIN JEREMY M CEO | Purchase | +8,488 | $5.84 | $50K | 5,792,530 |
| 2019-09-20 | LEVIN JEREMY M CEO | Gift | −465,116 | 0 |
Page 7 of 7 · 123 trades